Identification of isobutyryl-CoA dehydrogenase and its deficiency in humans
Identification of isobutyryl-CoA dehydrogenase and its deficiency in humans
复制标题
DOI:
10.1016/s1096-7192(02)00152-x
复制
发表时间:
2002-09-01
影响因子:
3.8
通讯作者:
Vockley, J
中科院分区:
文献类型:
--
作者:
Nguyen, TV;Andresen, BS;Vockley, J
The acyl-CoA dehydrogenases (ACDs) are a family of related enzymes that catalyze the alpha,beta-dehydrogenation of acyl-CoA esters. Two homologues active in branched chain amino acid metabolism have previously been identified. We have used expression in Escherichia coli to produce a previously uncharacterized ACD-like sequence (ACAD8) and define its substrate specificity. Purified recombinant enzyme had a k(cat)/K-m of 0.8, 0.23, and 0.04 (muM(-1)s(-1)) with isobutyryl-CoA, (S) 2-methylbutyryl-CoA, and n-propionyl-CoA, respectively, as substrates. Thus, this enzyme is an isobutyryl-CoA dehydrogenase. A single patient has previously been described whose fibroblasts exhibit a specific deficit in the oxidation of valine. Amplified A CAD8 cDNA made from patient fibroblast mRNA was homozygous for a single nucleotide change (905G > A) in the A CAD8 coding re.-ion compared to the sequence from control cells. This encodes an Arg302Gln substitution in the full-length protein (position 280 in the mature protein), a position predicted by molecular modeling to be important in subunit interactions. The mutant enzyme was stable but inactive when expressed in E coli. It was also stable and appropriately targeted to mitochondria, but inactive when expressed in mammalian cells. These data confirm further the presence of a separated ACD in humans specific to valine catabolism (isobutyryl-CoA dehydrogenase, IBDH), along with the first enzymatic and molecular confirmation of a deficiency of this enzyme in a patient. (C) 2002 Elsevier Science (USA). All rights reserved.